{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T06:29:53Z","timestamp":1773642593250,"version":"3.50.1"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,1,3]],"date-time":"2014-01-03T00:00:00Z","timestamp":1388707200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1007\/s40266-013-0137-1","type":"journal-article","created":{"date-parts":[[2014,1,2]],"date-time":"2014-01-02T12:25:10Z","timestamp":1388665510000},"page":"111-123","source":"Crossref","is-referenced-by-count":9,"title":["The Association Between Drugs Frequently Used by the Elderly and Vitamin D Blood Levels: A Review of Observational and Experimental Studies"],"prefix":"10.1007","volume":"31","author":[{"given":"Anne Claire B.","family":"van Orten-Luiten","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9","family":"Janse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosalie A. M.","family":"Dhonukshe-Rutten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renger F.","family":"Witkamp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,1,3]]},"reference":[{"issue":"13","key":"137_CR1","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1001\/archinternmed.2010.153","volume":"170","author":"G Onder","year":"2010","unstructured":"Onder G, Petrovic M, Tangiisuran B, et al. Development and validation of a score to assess risk of adverse drug reactions among in-hospital patients 65\u00a0years or older: the GerontoNet ADR risk score. Arch Intern Med. 2010;170(13):1142\u20138.","journal-title":"Arch Intern Med"},{"issue":"4","key":"137_CR2","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/pds.1565","volume":"17","author":"CS Hooft van der","year":"2008","unstructured":"van der Hooft CS, Dieleman JP, Siemes C, et al. Adverse drug reaction-related hospitalisations: a population-based cohort study. Pharmacoepidemiol Drug Saf. 2008;17(4):365\u201371.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"137_CR3","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jada.2011.09.002","volume":"112","author":"JI Boullata","year":"2012","unstructured":"Boullata JI, Hudson LM. Drug-nutrient interactions: a broad view with implications for practice. J Acad Nutr Diet. 2012;112(4):506\u201317.","journal-title":"J Acad Nutr Diet"},{"issue":"12","key":"137_CR4","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1592\/phco.2005.25.12.1789","volume":"25","author":"CA Santos","year":"2005","unstructured":"Santos CA, Boullata JI. An approach to evaluating drug-nutrient interactions. Pharmacotherapy. 2005;25(12):1789\u2013800.","journal-title":"Pharmacotherapy"},{"issue":"10 Suppl 2","key":"137_CR5","doi-asserted-by":"crossref","first-page":"S153","DOI":"10.1111\/j.1753-4887.2008.00100.x","volume":"66","author":"A Prentice","year":"2008","unstructured":"Prentice A, Vitamin D. Deficiency: a global perspective. Nutr Rev. 2008;66(10 Suppl 2):S153\u201364.","journal-title":"Nutr Rev"},{"issue":"5","key":"137_CR6","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.3945\/ajcn.2009.28908","volume":"91","author":"AE Millen","year":"2010","unstructured":"Millen AE, Wactawski-Wende J, Pettinger M, et al. Predictors of serum 25-hydroxyvitamin D concentrations among postmenopausal women: the Women\u2019s Health Initiative Calcium plus Vitamin D clinical trial. Am J Clin Nutr. 2010;91(5):1324\u201335.","journal-title":"Am J Clin Nutr"},{"key":"137_CR7","doi-asserted-by":"crossref","unstructured":"Murr C, Pilz S, Grammer TB, Kleber ME, et al. Vitamin D deficiency parallels inflammation and immune activation, the Ludwigshafen Risk and Cardiovascular Health (LURIC) study. Clin Chem Lab Med. 2012;50(12):2065\u2013250.","DOI":"10.1515\/cclm-2012-0157"},{"issue":"28","key":"137_CR8","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1177\/0884533612467824","volume":"10","author":"K Robien","year":"2013","unstructured":"Robien K, Oppeneer SJ, Kelly JA, et al. Drug-vitamin D interactions: a systematic review of the literature. Nutr Clin Pract. 2013;10(28):194\u2013208.","journal-title":"Nutr Clin Pract"},{"issue":"2","key":"137_CR9","doi-asserted-by":"crossref","first-page":"158","DOI":"10.4161\/derm.20731","volume":"4","author":"U Grober","year":"2012","unstructured":"Grober U, Kisters K. Influence of drugs on vitamin D and calcium metabolism. Dermatoendocrinol. 2012;4(2):158\u201366.","journal-title":"Dermatoendocrinol"},{"issue":"3","key":"137_CR10","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1530\/EJE-11-0917","volume":"166","author":"E Sohl","year":"2012","unstructured":"Sohl E, van Schoor NM, de Jongh RT, et al. The impact of medication on vitamin D status in older individuals. Eur J Endocrinol. 2012;166(3):477\u201385.","journal-title":"Eur J Endocrinol"},{"key":"137_CR11","volume-title":"Is use of medication associated with blood levels of micronutrients? A cross-sectional study of a Dutch geriatric hospital population [MSc]","author":"ACB Orten-Luiten van","year":"2012","unstructured":"van Orten-Luiten ACB. Is use of medication associated with blood levels of micronutrients? A cross-sectional study of a Dutch geriatric hospital population [MSc]. Wageningen: Wageningen University; 2012."},{"key":"137_CR12","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology of the Norwegian Institute of Public Health: The ATC\/DDD system: The Anatomical Therapeutic Chemical classification system and the Defined Daily Dose. Oslo, Norway: Norwegian Institute of Public Health. Available from: http:\/\/www.whocc.no\/ ."},{"issue":"8","key":"137_CR13","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1097\/MPH.0b013e31817541a8","volume":"30","author":"M Avgeri","year":"2008","unstructured":"Avgeri M, Papadopoulou A, Platokouki H, et al. Assessment of bone mineral density and markers of bone turnover in children under long-term oral anticoagulant therapy. J Pediatr Hematol Oncol. 2008;30(8):592\u20137.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"1\u20132","key":"137_CR14","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s004670000425","volume":"15","author":"MG Seikaly","year":"2000","unstructured":"Seikaly MG, Quigley R, Baum M. Effect of dipyridamole on serum and urinary phosphate in X-linked hypophosphatemia. Pediatr Nephrol. 2000;15(1\u20132):57\u20139.","journal-title":"Pediatr Nephrol"},{"issue":"5","key":"137_CR15","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0026-0495(85)90206-9","volume":"34","author":"B Riis","year":"1985","unstructured":"Riis B, Christiansen C. Actions of thiazide on vitamin D metabolism: a controlled therapeutic trial in normal women early in the postmenopause. Metabolism. 1985;34(5):421\u20134.","journal-title":"Metabolism"},{"issue":"6","key":"137_CR16","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1210\/jcem-59-6-1037","volume":"59","author":"K Sakhaee","year":"1984","unstructured":"Sakhaee K, Nicar MJ, Glass K, et al. Reduction in intestinal calcium absorption by hydrochlorothiazide in postmenopausal osteoporosis. J Clin Endocrinol Metab. 1984;59(6):1037\u201343.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"137_CR17","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1600-0773.1995.tb01036.x","volume":"77","author":"A Manninen","year":"1995","unstructured":"Manninen A, Wuorela H, Laippala P, et al. Intraplatelet free calcium and calcium-regulating hormones in plasma are not related to the antihypertensive effect of nifedipine in hypertensive pregnancy. Pharmacol Toxicol. 1995;77(5):327\u201332.","journal-title":"Pharmacol Toxicol"},{"issue":"9","key":"137_CR18","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1046\/j.1365-2362.2001.00883.x","volume":"31","author":"L Rejnmark","year":"2001","unstructured":"Rejnmark L, Vestergaard P, Heickendorff L, et al. Loop diuretics alter the diurnal rhythm of endogenous parathyroid hormone secretion. A randomized-controlled study on the effects of loop- and thiazide-diuretics on the diurnal rhythms of calcitropic hormones and biochemical bone markers in postmenopausal women. Eur J Clin Invest. 2001;31(9):764\u201372.","journal-title":"Eur J Clin Invest"},{"issue":"8","key":"137_CR19","doi-asserted-by":"crossref","first-page":"658","DOI":"10.7326\/0003-4819-130-8-199904200-00012","volume":"130","author":"JS Adams","year":"1999","unstructured":"Adams JS, Song CF, Kantorovich V. Rapid recovery of bone mass in hypercalciuric, osteoporotic men treated with hydrochlorothiazide. Ann Intern Med. 1999;130(8):658\u201360.","journal-title":"Ann Intern Med"},{"key":"137_CR20","doi-asserted-by":"crossref","unstructured":"Lo Cascio V, Adami S, Tartarotti D, et al. Aberration in vitamin D metabolism during mianserin treatment. Lancet. 1984 Apr 28;1(8383):958\u20139.","DOI":"10.1016\/S0140-6736(84)92410-3"},{"key":"137_CR21","unstructured":"Demir C, Mousa U, Anil C, et al. Effects of atorvastatin and rosuvastatin therapy on serum 25-hydroxyvitamin D levels: a comparative study. In: Abstracts E, editor. European Congress of Endocrinology 2011; 30 April 2011\u201304 May 2011. Rotterdam: BioScientifica; 2011. p. P548.1."},{"issue":"10","key":"137_CR22","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1002\/jbmr.108","volume":"25","author":"MJ Wright","year":"2010","unstructured":"Wright MJ, Sullivan RR, Gaffney-Stomberg E, et al. Inhibiting gastric acid production does not affect intestinal calcium absorption in young, healthy individuals: a randomized, crossover, controlled clinical trial. J Bone Miner Res. 2010;25(10):2205\u201311.","journal-title":"J Bone Miner Res"},{"key":"137_CR23","doi-asserted-by":"crossref","unstructured":"Hansen KE, Jones AN, Lindstrom MJ, Davis LA, et al. Do proton pump inhibitors decrease calcium absorption? J Bone Miner Res. 2010;25(12):2786\u201395.","DOI":"10.1002\/jbmr.166"},{"issue":"4","key":"137_CR24","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.metabol.2012.09.011","volume":"62","author":"AI Sharara","year":"2012","unstructured":"Sharara AI, El-Halabi MM, Ghaith OA, et al. Proton Pump inhibitors have no measurable effect on calcium and bone metabolism in healthy young males: a prospective matched controlled study. Metabolism. 2012;62(4):518\u201326.","journal-title":"Metabolism"},{"issue":"11","key":"137_CR25","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1373\/clinchem.2010.144014","volume":"56","author":"T Sathyapalan","year":"2010","unstructured":"Sathyapalan T, Shepherd J, Arnett C, et al. Atorvastatin increases 25-hydroxy vitamin D concentrations in patients with polycystic ovary syndrome. Clin Chem. 2010;56(11):1696\u2013700.","journal-title":"Clin Chem"},{"key":"137_CR26","doi-asserted-by":"crossref","unstructured":"Kos E, Liszek MJ, Emanuele MA, et al. Effect of metformin therapy on vitamin D and vitamin B12 levels in patients with type 2 diabetes mellitus. Endocr Pract. 2012;18(2):179\u201384.","DOI":"10.4158\/EP11009.OR"},{"issue":"4","key":"137_CR27","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1507\/endocrj.K06-001","volume":"53","author":"A Suzuki","year":"2006","unstructured":"Suzuki A, Kotake M, Ono Y, et al. Hypovitaminosis D in type 2 diabetes mellitus: association with microvascular complications and type of treatment. Endocr J. 2006;53(4):503\u201310.","journal-title":"Endocr J"},{"issue":"Suppl 1","key":"137_CR28","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0167-4943(96)86948-2","volume":"22","author":"PD Ragonesi","year":"1996","unstructured":"Ragonesi PD, Taddei MT, Ragonesi G, et al. Influence of diabetic treatment regimens on vitamin D metabolism in elderly patients. Arch Gerontol Geriatr. 1996;22(Suppl 1):271\u20134.","journal-title":"Arch Gerontol Geriatr"},{"issue":"1","key":"137_CR29","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000256650","volume":"29","author":"Y Sato","year":"2010","unstructured":"Sato Y, Honda Y, Jun I. Long-term oral anticoagulation therapy and the risk of hip fracture in patients with previous hemispheric infarction and nonrheumatic atrial fibrillation. Cerebrovasc Dis. 2010;29(1):73\u20138.","journal-title":"Cerebrovasc Dis"},{"issue":"12","key":"137_CR30","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1161\/01.STR.28.12.2390","volume":"28","author":"Y Sato","year":"1997","unstructured":"Sato Y, Honda Y, Kunoh H, et al. Long-term oral anticoagulation reduces bone mass in patients with previous hemispheric infarction and nonrheumatic atrial fibrillation. Stroke. 1997;28(12):2390\u20134.","journal-title":"Stroke"},{"issue":"2","key":"137_CR31","first-page":"71","volume":"112","author":"E Stenova","year":"2011","unstructured":"Stenova E, Steno B, Killinger Z, et al. Effect of long-term oral anticoagulant therapy on bone mineral density and bone turnover markers: a prospective 12\u00a0month study. Bratisl Lek Listy. 2011;112(2):71\u20136.","journal-title":"Bratisl Lek Listy"},{"issue":"7","key":"137_CR32","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1681\/ASN.V971264","volume":"9","author":"D Prie","year":"1998","unstructured":"Prie D, Blanchet FB, Essig M, et al. Dipyridamole decreases renal phosphate leak and augments serum phosphorus in patients with low renal phosphate threshold. J Am Soc Nephrol. 1998;9(7):1264\u20139.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"137_CR33","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1007\/s00198-011-1692-0","volume":"23","author":"P Vestergaard","year":"2012","unstructured":"Vestergaard P, Hermann P, Jensen JE, et al. Effects of paracetamol, non-steroidal anti-inflammatory drugs, acetylsalicylic acid, and opioids on bone mineral density and risk of fracture: results of the Danish Osteoporosis Prevention Study (DOPS). Osteoporos Int. 2012;23(4):1255\u201365.","journal-title":"Osteoporos Int"},{"issue":"3","key":"137_CR34","doi-asserted-by":"crossref","first-page":"722","DOI":"10.2337\/diacare.29.03.06.dc05-2148","volume":"29","author":"M Cigolini","year":"2006","unstructured":"Cigolini M, Iagulli MP, Miconi V, et al. Serum 25-hydroxyvitamin D3 concentrations and prevalence of cardiovascular disease among type 2 diabetic patients. Diabetes Care. 2006;29(3):722\u20134.","journal-title":"Diabetes Care"},{"issue":"1","key":"137_CR35","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1046\/j.1365-2362.2003.01103.x","volume":"33","author":"L Rejnmark","year":"2003","unstructured":"Rejnmark L, Vestergaard P, Pedersen AR, et al. Dose-effect relations of loop- and thiazide-diuretics on calcium homeostasis: a randomized, double-blinded Latin-square multiple cross-over study in postmenopausal osteopenic women. Eur J Clin Invest. 2003;33(1):41\u201350.","journal-title":"Eur J Clin Invest"},{"issue":"2","key":"137_CR36","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1046\/j.1365-2796.2001.00868.x","volume":"250","author":"L Rejnmark","year":"2001","unstructured":"Rejnmark L, Vestergaard P, Heickendorff L, et al. Effects of thiazide- and loop-diuretics, alone or in combination, on calcitropic hormones and biochemical bone markers: a randomized controlled study. J Intern Med. 2001;250(2):144\u201353.","journal-title":"J Intern Med"},{"issue":"5","key":"137_CR37","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S0002-9343(00)00510-6","volume":"109","author":"IR Reid","year":"2000","unstructured":"Reid IR, Ames RW, Orr-Walker BJ, et al. Hydrochlorothiazide reduces loss of cortical bone in normal postmenopausal women: a randomized controlled trial. Am J Med. 2000;109(5):362\u201370.","journal-title":"Am J Med"},{"issue":"2","key":"137_CR38","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0022-5347(17)40737-3","volume":"141","author":"KL Insogna","year":"1989","unstructured":"Insogna KL, Ellison AS, Burtis WJ, et al. Trichlormethiazide and oral phosphate therapy in patients with absorptive hypercalciuria. J Urol. 1989;141(2):269\u201374.","journal-title":"J Urol"},{"issue":"8","key":"137_CR39","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1007\/BF00180287","volume":"70","author":"R Nowack","year":"1992","unstructured":"Nowack R, Hofner MC, Reichel H, et al. Subacute effects of thiazide administration on renal hemodynamics and calcium metabolism. Clin Investig. 1992;70(8):686\u201391.","journal-title":"Clin Investig"},{"key":"137_CR40","doi-asserted-by":"crossref","unstructured":"Calo L, Cantaro S, Marchini F, et al. Is hydrochlorothiazide-induced hypocalciuria due to inhibition of prostaglandin E2 synthesis? Clin Sci (Lond). 1990;78(3):321\u20135.","DOI":"10.1042\/cs0780321"},{"issue":"8","key":"137_CR41","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/BF03350753","volume":"12","author":"U Krause","year":"1989","unstructured":"Krause U, Zielke A, Schmidt-Gayk H, et al. Direct tubular effect on calcium retention by hydrochlorothiazide. J Endocrinol Invest. 1989;12(8):531\u20135.","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"137_CR42","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0026-0495(80)90091-8","volume":"29","author":"JE Zerwekh","year":"1980","unstructured":"Zerwekh JE, Pak CY. Selective effects of thiazide therapy on serum 1 alpha,25-dihydroxyvitamin D and intestinal calcium absorption in renal and absorptive hypercalciurias. Metabolism. 1980;29(1):13\u20137.","journal-title":"Metabolism"},{"key":"137_CR43","unstructured":"Laroche M, Mazieres B. Beneficial effect of a thiazide diuretic on bone mineral density in male osteoporosis with hypercalciuria. Clin Exp Rheumatol. 1998;16(1):109\u201310."},{"issue":"6","key":"137_CR44","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1038\/ki.1988.122","volume":"33","author":"FL Coe","year":"1988","unstructured":"Coe FL, Parks JH, Bushinsky DA, et al. Chlorthalidone promotes mineral retention in patients with idiopathic hypercalciuria. Kidney Int. 1988;33(6):1140\u20136.","journal-title":"Kidney Int"},{"issue":"6","key":"137_CR45","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/ki.1985.223","volume":"28","author":"J Lemann Jr","year":"1985","unstructured":"Lemann J Jr, Gray RW, Maierhofer WJ, et al. Hydrochlorothiazide inhibits bone resorption in men despite experimentally elevated serum 1,25-dihydroxyvitamin D concentrations. Kidney Int. 1985;28(6):951\u20138.","journal-title":"Kidney Int"},{"issue":"1","key":"137_CR46","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0169-6009(08)80119-5","volume":"21","author":"B Dawson-Hughes","year":"1993","unstructured":"Dawson-Hughes B, Harris S. Thiazides and seasonal bone change in healthy postmenopausal women. Bone Miner. 1993;21(1):41\u201351.","journal-title":"Bone Miner"},{"issue":"4","key":"137_CR47","first-page":"188","volume":"16","author":"F Kokot","year":"1981","unstructured":"Kokot F, Pietrek J, Srokowska S, et al. 25-hydroxyvitamin D in patients with essential hypertension. Clin Nephrol. 1981;16(4):188\u201392.","journal-title":"Clin Nephrol"},{"issue":"5","key":"137_CR48","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.jamda.2007.01.099","volume":"8","author":"PJ Drinka","year":"2007","unstructured":"Drinka PJ, Krause PF, Nest LJ, et al. Determinants of parathyroid hormone levels in nursing home residents. J Am Med Dir Assoc. 2007;8(5):328\u201331.","journal-title":"J Am Med Dir Assoc"},{"issue":"2","key":"137_CR49","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0169-6009(90)90089-X","volume":"10","author":"MR Sowers","year":"1990","unstructured":"Sowers MR, Wallace RB, Hollis BW. The relationship of 1,25-dihydroxyvitamin D and radial bone mass. Bone Miner. 1990;10(2):139\u201348.","journal-title":"Bone Miner"},{"issue":"8","key":"137_CR50","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1111\/j.1532-5415.1993.tb06176.x","volume":"41","author":"HM Perry 3rd","year":"1993","unstructured":"Perry HM 3rd, Jensen J, Kaiser FE, et al. The effects of thiazide diuretics on calcium metabolism in the aged. J Am Geriatr Soc. 1993;41(8):818\u201322.","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"137_CR51","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1359\/JBMR.051003","volume":"21","author":"L Rejnmark","year":"2006","unstructured":"Rejnmark L, Vestergaard P, Heickendorff L, et al. Loop diuretics increase bone turnover and decrease BMD in osteopenic postmenopausal women: results from a randomized controlled study with bumetanide. J Bone Miner Res. 2006;21(1):163\u201370.","journal-title":"J Bone Miner Res"},{"issue":"2","key":"137_CR52","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1365-2796.2004.01434.x","volume":"257","author":"L Rejnmark","year":"2005","unstructured":"Rejnmark L, Vestergaard P, Heickendorff L, et al. Effects of long-term treatment with loop diuretics on bone mineral density, calcitropic hormones and bone turnover. J Intern Med. 2005;257(2):176\u201384.","journal-title":"J Intern Med"},{"issue":"1","key":"137_CR53","first-page":"8","volume":"7","author":"H Reichel","year":"1992","unstructured":"Reichel H, Deibert B, Geberth S, et al. Frusemide therapy and intact parathyroid hormone plasma concentrations in chronic renal insufficiency. Nephrol Dial Transplant. 1992;7(1):8\u201315.","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl 5","key":"137_CR54","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/BF02018305","volume":"4","author":"L Calo","year":"1990","unstructured":"Calo L, Cantaro S, Piccoli A, et al. Effect of nifedipine on urinary excretion of calcium and calcium-controlling hormones in essential hypercalciuria. Cardiovasc Drugs Ther. 1990;4(Suppl 5):983\u20136.","journal-title":"Cardiovasc Drugs Ther"},{"issue":"12 Pt 1","key":"137_CR55","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1093\/ajh\/2.12.927","volume":"2","author":"LM Resnick","year":"1989","unstructured":"Resnick LM, Nicholson JP, Laragh JH. The effects of calcium channel blockade on blood pressure and calcium metabolism. Am J Hypertens. 1989;2(12 Pt 1):927\u201330.","journal-title":"Am J Hypertens"},{"issue":"Suppl 6","key":"137_CR56","doi-asserted-by":"crossref","first-page":"S114","DOI":"10.1097\/00005344-198812006-00028","volume":"12","author":"LM Resnick","year":"1988","unstructured":"Resnick LM, Nicholson JP, Laragh JH. The antihypertensive effects of calcium channel blockade: role of sodium and calcium metabolism. J Cardiovasc Pharmacol. 1988;12(Suppl 6):S114\u20136.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"3","key":"137_CR57","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00000441-199009000-00001","volume":"300","author":"R Townsend","year":"1990","unstructured":"Townsend R, DiPette DJ, Evans RR, et al. Effects of calcium channel blockade on calcium homeostasis in mild to moderate essential hypertension. Am J Med Sci. 1990;300(3):133\u20137.","journal-title":"Am J Med Sci"},{"issue":"4","key":"137_CR58","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/clpt.1988.172","volume":"44","author":"GS Hughes Jr","year":"1988","unstructured":"Hughes GS Jr, Cowart TD, Oexmann MJ, et al. Verapamil-induced natriuretic and diuretic effects: dependency on sodium intake. Clin Pharmacol Ther. 1988;44(4):400\u20137.","journal-title":"Clin Pharmacol Ther"},{"issue":"24","key":"137_CR59","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1007\/BF01785712","volume":"64","author":"W Riegel","year":"1986","unstructured":"Riegel W, Horl WH, Heidland A. Long-term effects of nifedipine on plasma levels of 25 hydroxyvitamin D and 1,25 dihydroxyvitamin D in hypertensive hemodialyzed patients. Klin Wochenschr. 1986;64(24):1291.","journal-title":"Klin Wochenschr"},{"issue":"1","key":"137_CR60","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/8756-3282(91)90053-L","volume":"12","author":"MM Albers","year":"1991","unstructured":"Albers MM, Johnson W, Vivian V, et al. Chronic use of the calcium channel blocker nifedipine has no significant effect on bone metabolism in men. Bone. 1991;12(1):39\u201342.","journal-title":"Bone"},{"issue":"12","key":"137_CR61","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1055\/s-2006-956500","volume":"38","author":"JL Perez-Castrillon","year":"2006","unstructured":"Perez-Castrillon JL, Justo I, Sanz A, et al. Effect of angiotensin converting enzyme inhibitors on 1.25-(OH)2 D levels of hypertensive patients. Relationship with ACE polymorphisms. Horm Metab Res. 2006;38(12):812\u20136.","journal-title":"Horm Metab Res"},{"issue":"6","key":"137_CR62","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0895-7061(03)00845-8","volume":"16","author":"JL Perez-Castrillon","year":"2003","unstructured":"Perez-Castrillon JL, Silva J, Justo I, et al. Effect of quinapril, quinapril-hydrochlorothiazide, and enalapril on the bone mass of hypertensive subjects: relationship with angiotensin converting enzyme polymorphisms. Am J Hypertens. 2003;16(6):453\u20139.","journal-title":"Am J Hypertens"},{"issue":"7","key":"137_CR63","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.amjcard.2006.11.036","volume":"99","author":"JL Perez-Castrillon","year":"2007","unstructured":"Perez-Castrillon JL, Vega G, Abad L, Sanz A, Chaves J, et al. Effects of Atorvastatin on vitamin D levels in patients with acute ischemic heart disease. Am J Cardiol. 2007;99(7):903\u20135.","journal-title":"Am J Cardiol"},{"issue":"1\u20132","key":"137_CR64","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jsbmb.2011.09.002","volume":"128","author":"CR Doorenbos","year":"2012","unstructured":"Doorenbos CR, de Cuba MM, Vogt L, et al. Antiproteinuric treatment reduces urinary loss of vitamin D-binding protein but does not affect vitamin D status in patients with chronic kidney disease. J Steroid Biochem Mol Biol. 2012;128(1\u20132):56\u201361.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"137_CR65","unstructured":"Perez-Castrillon JL, De Luis D, Inglada L, et al. Telmisartan effect\u2019s on remodelling bone markers in hypertensive patients. Nutr Hosp. 2012;27(1):276\u201380."},{"issue":"8","key":"137_CR66","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.amjcard.2007.05.024","volume":"100","author":"JF Aloia","year":"2007","unstructured":"Aloia JF, Li-Ng M, Pollack S. Statins and vitamin D. Am J Cardiol. 2007;100(8):1329.","journal-title":"Am J Cardiol"},{"key":"137_CR67","doi-asserted-by":"crossref","first-page":"957174","DOI":"10.1155\/2010\/957174","volume":"2010","author":"L Rejnmark","year":"2010","unstructured":"Rejnmark L, Vestergaard P, Heickendorff L, et al. Simvastatin does not affect vitamin d status, but low vitamin d levels are associated with dyslipidemia: results from a randomised, controlled trial. Int J Endocrinol. 2010;2010:957174.","journal-title":"Int J Endocrinol"},{"key":"137_CR68","doi-asserted-by":"crossref","unstructured":"Sathyapalan T, Shepherd J, Atkin SL, et al. The effect of atorvastatin and simvastatin on vitamin D, oxidative stress and inflammatory marker concentrations in patients with type 2 diabetes: a crossover study. Diabetes Obes Metab. 2013;15(8):767\u20139.","DOI":"10.1111\/dom.12074"},{"key":"137_CR69","first-page":"1","volume":"2","author":"EN Liberopoulos","year":"2013","unstructured":"Liberopoulos EN, Makariou SE, Moutzouri E, et al. Effect of simvastatin\/ezetimibe 10\/10\u00a0mg versus simvastatin 40\u00a0mg on serum vitamin D levels. J Cardiovasc Pharmacol Ther. 2013;2:1\u20135.","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"137_CR70","doi-asserted-by":"crossref","unstructured":"Ertugrul DT, Yavuz B, Cil H, et al. STATIN-D study: comparison of the influences of rosuvastatin and fluvastatin treatment on the levels of 25 hydroxyvitamin D. Cardiovascular Ther. 2011;29(2):146\u201352.","DOI":"10.1111\/j.1755-5922.2010.00141.x"},{"key":"137_CR71","unstructured":"Ismail F, Corder CN, Epstein S, et al. Effects of pravastatin and cholestyramine on circulating levels of parathyroid hormone and vitamin D metabolites. Clin Ther. 1990;12(5):427\u201330."},{"key":"137_CR72","unstructured":"Montagnani M, Lore F, Di Cairano G, et al. Effects of pravastatin treatment on vitamin D metabolites. Clin Ther. 1994;16(5):824\u20139."},{"issue":"5","key":"137_CR73","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/0026-0495(91)90235-O","volume":"40","author":"AS Dobs","year":"1991","unstructured":"Dobs AS, Levine MA, Margolis S. Effects of pravastatin, a new HMG-CoA reductase inhibitor, on vitamin D synthesis in man. Metabolism. 1991;40(5):524\u20138.","journal-title":"Metabolism"},{"key":"137_CR74","doi-asserted-by":"crossref","unstructured":"Ott C, Raff U, Schneider MP, et al. 25-hydroxyvitamin D insufficiency is associated with impaired renal endothelial function and both are improved with rosuvastatin treatment. Clin Res Cardiol. 2013\u00a0;102(4)\u00a0:299\u2013304.","DOI":"10.1007\/s00392-012-0534-1"},{"issue":"4","key":"137_CR75","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1177\/1074248412439470","volume":"17","author":"SE Makariou","year":"2012","unstructured":"Makariou SE, Liberopoulos EN, Agouridis AP, et al. Effect of rosuvastatin monotherapy and in combination with fenofibrate or omega-3 fatty acids on serum vitamin D levels. J Cardiovasc Pharmacol Ther. 2012;17(4):382\u20136.","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"137_CR76","doi-asserted-by":"crossref","unstructured":"Yavuz B, Ertugrul DT, Cil H, et al. Increased levels of 25 hydroxyvitamin D and 1,25-dihydroxyvitamin D after rosuvastatin treatment: a novel pleiotropic effect of statins? Cardiovasc Drugs Ther. 2009;23(4):295\u20139.","DOI":"10.1007\/s10557-009-6181-8"},{"issue":"4","key":"137_CR77","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s12603-011-0361-5","volume":"16","author":"V Verhoeven","year":"2012","unstructured":"Verhoeven V, Vanpuyenbroeck K, Lopez-Hartmann M, et al. Walk on the sunny side of life\u2013epidemiology of hypovitaminosis D and mental health in elderly nursing home residents. J Nutr Health Aging. 2012;16(4):417\u201320.","journal-title":"J Nutr Health Aging"},{"key":"137_CR78","first-page":"7","volume":"243","author":"G Jones","year":"2012","unstructured":"Jones G. Metabolism and biomarkers of vitamin D. Scand J Clin Lab Invest Suppl. 2012;243:7\u201313.","journal-title":"Scand J Clin Lab Invest Suppl"},{"key":"137_CR79","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0083-6729(07)00016-7","volume":"78","author":"S Bugel","year":"2008","unstructured":"Bugel S, Vitamin K. Vitamin K and bone health in adult humans. Vitam Horm. 2008;78:393\u2013416.","journal-title":"Vitam Horm"},{"issue":"6","key":"137_CR80","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1097\/FTD.0b013e31815c16f5","volume":"29","author":"SF Zhou","year":"2007","unstructured":"Zhou SF, Xue CC, Yu XQ, et al. Clinically important drug interactions potentially involving mechanism-based inhibition of cytochrome P450 3A4 and the role of therapeutic drug monitoring. Ther Drug Monit. 2007;29(6):687\u2013710.","journal-title":"Ther Drug Monit"},{"issue":"2","key":"137_CR81","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/sj.ki.5002002","volume":"71","author":"M Chonchol","year":"2007","unstructured":"Chonchol M, Scragg R. 25-Hydroxyvitamin D, insulin resistance, and kidney function in the Third National Health and Nutrition Examination Survey. Kidney Int. 2007;71(2):134\u20139.","journal-title":"Kidney Int"},{"key":"137_CR82","doi-asserted-by":"crossref","unstructured":"Gama R, Waldron JL, Ashby HL, et al. Hypovitaminosis D and disease: consequence rather than cause? BMJ. 2012;345:e5706.","DOI":"10.1136\/bmj.e5706"},{"issue":"5","key":"137_CR83","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1365-2796.2010.02267.x","volume":"268","author":"C Ding","year":"2010","unstructured":"Ding C, Parameswaran V, Blizzard L, et al. Not a simple fat-soluble vitamin: changes in serum 25-(OH)D levels are predicted by adiposity and adipocytokines in older adults. J Intern Med. 2010;268(5):501\u201310.","journal-title":"J Intern Med"},{"key":"137_CR84","doi-asserted-by":"crossref","unstructured":"Querfeld U. Vitamin D and inflammation. Pediatr Nephrol. 2012;28(4):605\u201310.","DOI":"10.1007\/s00467-012-2377-4"},{"key":"137_CR85","doi-asserted-by":"crossref","unstructured":"Milaneschi Y, Hoogendijk W, Lips P, et al. The association between low vitamin D and depressive disorders. Mol Psychiatry. Epub 2013 Apr 9.","DOI":"10.1038\/mp.2013.36"},{"issue":"21","key":"137_CR86","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1007\/BF01726873","volume":"64","author":"W Riegel","year":"1986","unstructured":"Riegel W, Horl WH, Heidland A. Long-term effects of nifedipine on carbohydrate and lipid metabolism in hypertensive hemodialyzed patients. Klin Wochenschr. 1986;64(21):1124\u201330.","journal-title":"Klin Wochenschr"}],"container-title":["Drugs & Aging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-013-0137-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40266-013-0137-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-013-0137-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T04:26:42Z","timestamp":1647836802000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40266-013-0137-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,3]]},"references-count":86,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["137"],"URL":"https:\/\/doi.org\/10.1007\/s40266-013-0137-1","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,3]]}}}